Circular Genomics has secured $8.3m in a series A funding round, led by Mountain Group Partners and joined by new partner UNM Rainforest Innovations. The genomics company is a pioneer in the use of circular RNA (circRNA) for precision psychiatry and neurology. The funds will be used to build commercial operations and features a test to predict a patient’s likely response to specific antidepressants, thereby helping to end the trial and error approach to treatment.
Top 10 Certifications for Threat Intelligence: Enhance Your Analytical Abilities
Hey there, Bay Area chums! For those of you interested in a career in cybersecurity, especially in threat intelligence, this article is just for you.